Introduction {#sec1}
============

Aging society coupled with increasing incidence and prevalence of dementia (Fendrich and Hoffmann, [@ref015]; Hampel *et al*., [@ref018]) is a major challenge for the German healthcare system. Since causal treatment of dementia is still out of sight, there is a considerable need for new and more effective ways of dementia care to address the impending healthcare crisis (Naylor *et al*., [@ref029]).

The complexity of dementia demands comprehensive individualized care that addresses physical, psychological, social, and legal issues of the persons with dementia (PwDs) as well as their caregivers. The established healthcare system in Germany offers a broad range of healthcare services such as GPs, neurologists, psychiatrists, pharmacists, geriatric rehabilitation, qualified nursing care with diverse ambulatory services and in- and outpatient facilities, self-help groups, or caregiver counseling. However, fragmentation of these services as well as deficient communication and integration between them is a major problem and as a result utilization depends too often on individual, regional, logistic, or structural variables (Reuben *et al*., [@ref033]; Thyrian *et al*., [@ref036]). Therefore, integration and coordination rather than duplication of established services seems to be the method of choice to optimize dementia care in the ambulant sector.

As the majority of PwDs are treated by their GP, the primary care sector plays a key role in optimizing dementia care (Wagner and Abholz, [@ref040]). Recent studies show the effectiveness of collaborative care for PwDs in the primary care setting (Callahan *et al*., [@ref008]; Vickrey *et al*., [@ref038]). A review of six RCTs with case management programs for PwDs indicates that case management intensity and the integration level between health and social service organizations relate to greater efficacy (Somme *et al*., [@ref035]). However, since all, but one, studies were conducted in the USA, it remains unclear whether results can be readily generalized to the healthcare system in Germany.

Most PwDs wish to remain in their homes as long as possible. To allow adequate home care the support by an informal caregiver is usually required, particularly in later stages of dementia. However, caregivers carry a high burden. Studies show considerable impact on their physical and mental health (Black and Almeida, [@ref004]), often associated with earlier institutionalization of the PwDs (Mittelman *et al*., [@ref027]; Etters *et al*., [@ref014]). Hence, adequate support of caregivers is an indispensable part of any dementia care management.

With DelpHi-MV ("Dementia: life- and person-centered help in Mecklenburg-Western Pomerania") we want to implement and evaluate an innovative GP-based subsidiary support system for PwDs living at home and their caregivers. The DelpHi-Intervention is designed (1) to integrate multi-professional and multimodal strategies to optimize and individualize comprehensive treatment of dementia within the framework of the established healthcare and social service systems, (2) to diagnose cognitive impairment at an early stage to allow for early initiation of therapy as well as to take all necessary steps to prepare for progression of disease, (3) to address multimorbidity and its treatment that could interfere with dementia care or aggravate the course of dementia, and (4) to adequately address all relevant dimensions of caregiver burden.

Primary outcome measures of the intervention are: (1) improvement of quality of life (PwD, caregiver), (2) reduction of behavioral and psychological symptoms of dementia, (3) optimizing pharmacotherapy, and (4) reduction of caregiver burden (Thyrian *et al*., [@ref036]).

Purpose of this paper is to provide a comprehensive description of the DelpHi-Intervention.

Methods {#sec2}
=======

Design, setting, participants {#sec2-1}
-----------------------------

DelpHi-MV is a population-based cluster-randomized controlled intervention trial in the primary care setting; details (including sample size calculation) are described in the study protocol (Thyrian *et al*., [@ref036]). Enrolment into the study started in January 2012; the estimated primary completion date (first follow-up) is January 2015. Eligible patients (older than 70 years, living at home) of participating GP-practices are screened for cognitive impairment with the DemTect (Calabrese and Kessler, [@ref007]). Patients who meet the inclusion criteria (DemTect \<9) are informed by their GP about the study and are asked to participate and to sign a written consent. If the patient can name a caregiver, he or she is asked to participate as well. In case the patient is not able to give informed consent, his or her legal representative is asked to sign (as approved by the Ethical Committee of the Chamber of Physicians of Mecklenburg-Western Pomerania, registry number BB 20/11).

Participants and their caregivers are cluster-randomized into an intervention and a control group. Participating GP-practices in Mecklenburg-Western Pomerania represent the clusters for randomization (1:1 allocation ratio). Baseline and annual follow-up assessments are conducted identically in both groups. Whereas the control group receives "care as usual," the intervention group receives the "DelpHi-Intervention" (see [Figure 1](#fig001){ref-type="fig"} for an outline of the DelpHi-Intervention). The intervention is initiated and coordinated by Dementia Care Managers (DCMs), qualified nurses who received a dementia-specific training (Dreier *et al*., [@ref013]). Figure 1.Outline of DelpHi-Intervention.

Baseline assessment {#sec2-2}
-------------------

Patients who were included into the study are contacted by their designated DCM to arrange two to three personal visits at their homes to carry out a comprehensive standardized baseline assessment. The DCM collects standardized data regarding each patient\'s specific social, medical, psychological, pharmaceutical, and nursing situation to identify in detail the individual needs and resources of the PwD and his or her caregiver (for details see [Table 1](#tbl001){ref-type="table"}). Table 1.Instruments used at baseline and in-depth assessment[assessment type]{.smallcaps}[assessment of:]{.smallcaps}*Baseline assessment*Sociodemographic characteristics/social environment (age, marital status, children, household members, education, income, last professional position, living situation, persons who can take care on short notice): SDQPwD, CInformations about PwD (cognitive capacity for consent, power of attorney, Patient Decree, legal representative, Pflegestufe (care level), disabled pass, etc.) SDQ^3^Utilization of healthcare resources/social services/nursing aids: SDQ^2,3^PwD, CGeneral state of health: Extract from Standardized Assessment of Elderly People in primary care (STEP)^2,3^ (Sandholzer *et al*., [@ref034])PwD, CHealth-related quality of life: 12-Item Short Form Health Survey (SF-12)^2^ (Bullinger and Kirchberger, [@ref005])PwD, CActivities of daily livings: Bayer Activities of Daily Living Scale (B-ADL)^2,3^ (Hindmarch *et al*., [@ref019])PwDKnowledge about dementia, treatment options, and healthcare/social services: SDQ^3^PwDSocial support: Fragebogen zur sozialen Unterstützung (F-SozU)^2,3^ (Fydrich *et al*., [@ref017])PwDQuality of life: Quality of Life -- Alzeimer\'s Disease (Qol-AD)^1^ (Logsdon *et al*., [@ref023])PwDDepression: Geriatric Depression Scale (GDS)^2,3^ (Reisberg *et al*., [@ref032])PwDCognitive impairment/severity grading of cognitive dysfunction: Structured Interview for the Diagnosis of Dementia (SIDAM/SISCO)^2,3^ (Zaudig *et al*., [@ref046])PwDMedication (intake, drug-related problems, potentially inadequate medications, adherence): Home Medication Review (HMR)^1,2,3^ (Fiß *et al*., [@ref017a]; submitted)PwDComorbidities (hypertension, diabetes, stroke): SDQ^2^PwDPsychiatric symptoms: Neuropsychiatric Inventory (NPI)^1,3^ (Cummings, [@ref009])C→PwDMedical status (ICD-10 diagnosis, hospitalization): Patient record of GP^2,3^GP→PwDInformal care: Resource Utilization in Dementia (RUD)^2^ (Wimo *et al*., [@ref042])CCaregiver burden: Berliner Inventar zur Angehörigenbelastung Demenz (BIZA-D)^1,3^ (Zank *et al*., [@ref045]); Brief Symptom Inventory (BSI)^2^ (Derogatis and Melisaratos, [@ref011]); Patient Health Questionnaire (PHQ-D)^2^ (Löwe *et al*., [@ref024])C*In-depth assessment (Intervention)*Standard assessment conducted at each intervention visit (emergencies, state of health, medical consultations, hospitalization, changes in medication, falls, pain, change in cognitive impairment, liquid intake, blood pressure, blood sugar): SDQ^3^PwD, DCM→PwDNeurological or psychiatric symptoms: SDQ^3^PwD, DCM→PwDSuitability for rehabilitation: SDQ^3^PwD, DCM→PwDRestriction in mobility: Timed up & go^3^ (Podsiadlo and Richardson, [@ref031])PwDRisk of falling: Tinetti-Test^3^ (Tinetti, [@ref037])PwDCognitive performance: Mini-Mental State Examination (MMSE)^3^ (Kessler *et al*., [@ref021])PwDDepression: Mini International Neuropsychiatric Interview (M.I.N.I. Depression)^3^ (Lecrubier *et al*., [@ref022])PwDPain assessment: Beurteilung von Schmerzen bei Demenz (BESD)^3^ (Basler *et al*., [@ref001])DCM→PwDClinical Dementia Rating (CDR)^3^ (Berg, [@ref003])DCM→PwDSeverity of dementia: SDQ^3^DCM→PwDCare Needs Assessment for Dementia (CareNapD)^3^ (McWalter *et al*., [@ref025])DCM→PwDCaregiver burden: Healthy Age Brain Monitor (HABC)^3^ (Monahan *et al*., [@ref028])C[^1][^2][^3][^4]

The baseline assessment includes a home medication review (HMR; Fiß *et al*., [@ref017a]; submitted). The DCM records all drugs used by the PwD, including non-prescription medicines. In addition the DCM collects data about storage, usage (dosage, time to meal), adherence, adverse drug events, and other drug-related problems. For the intervention group this information is summarized and passed on to the regular pharmacy of the PwD, provided the PwD consented in forwarding this data and the specified pharmacy participates in the DelpHi-MV study as well. The pharmacist is trained to conduct the standardized DelpHi-medication review concerning drug-related problems such as double prescriptions, side effects, interactions, or potentially inappropriate medications that carry an increased risk of adverse drug events in elderly patients according to the German PRISCUS-list (Holt *et al*., [@ref020]). The resulting medication review including specific pharmaceutical advices is faxed to the study center. The DCM includes the medication review and the pharmacist\'s advice in her GP-information letter (see below). In case the regular pharmacy of a PwD is not participating, the DelpHi-MV study pharmacist conducts the medication review instead.

Intervention: the "DelpHi-Standard" {#sec2-3}
-----------------------------------

After baseline assessment the intervention group receives the DelpHi-Intervention according to the "DelpHi-Standard" for one year. The DelpHi-Standard was designed to optimize care for the PwDs and their caregivers according to the World Health Organization ([@ref043]) definition of health: "Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity." To meet this requirement, the intervention has to be complex, multi-professional, multimodal, and adjusted to individual needs and resources of the individual PwD and his or her caregiver as well as to local conditions.

The development of the DelpHi-Intervention is based on German guidelines for evidence-based diagnostic and treatment of dementia (DEGAM, [@ref010]; DGPPN and DGN, [@ref012]), a review of current literature (e.g. Vollmar *et al*., [@ref039]; Förstl, [@ref016]), meetings and symposia with experts in the field, and the scientific advisory board of DelpHi-MV. To describe the "DelpHi-Standard," three key areas -- the "pillars of intervention" -- where defined: (1) management of treatment and care, (2) medication management, and (3) caregiver support and education. Associated with these pillars are eight different action fields, where each action field includes several foci. Every focus comprises specific intervention modules that constitute the actual basis for the work of the DCM (see [Figure 2](#fig002){ref-type="fig"}). Figure 2.Optimum Care as "DelpHi-Standard": pillars, action fields, foci, and intervention modules (red marked area see [Figure 3](#fig003){ref-type="fig"}).

Each *intervention module* consists of defined algorithms that contain the trigger condition(s) derived from standardized baseline and/or in-depth assessment (see [Table 1](#tbl001){ref-type="table"}) that activate(s) a specific intervention task and at least one criterion for successful completion of that task (see [Figure 3](#fig003){ref-type="fig"}). Figure 3.Example of an intervention module.

The DelpHi-Intervention comprises 95 of such predefined intervention modules. Feasibility, adequacy, and acceptance of intervention modules were tested and revised during the pilot phase of the study (*n* = 6 GPs, *n* = 21 probands of intervention group). Since the study takes place in the setting of routine care new developments in treatment guidelines will be incorporated into the intervention, otherwise the intervention will not be modified while it is being tested.

The comprehensive list of intervention modules helps to ensure that (1) all PwDs and their caregivers receive tailored interventions according to their individual needs and resources, and (2) the DCM would not overlook any necessary aspects of DelpHi-Intervention despite its broad spectrum and complexity.

There are following different types of intervention modules, examples of which are shown in [Table 2](#tbl002){ref-type="table"}: Table 2.Examples for different types of intervention modules[intervention module]{.smallcaps}[if (trigger condition)]{.smallcaps}[then (intervention task)]{.smallcaps}[who is responsible?]{.smallcaps}[monitoring: criteria for completion of task]{.smallcaps}(1)In-depth assessment: DepressionGDS \>5 (mild to severe depression) AND/OR NPI-16: Depression (scale D): frequency ≥ 3 AND severity ≥ 1 AND/OR standard monitoring: clinical impression of DCM: "depressive"Conduct M.I.N.I. DepressionDCMM.I.N.I. Depression conducted(2)Case conference: Neurological symptomsSemi-paralysis OR facial paralysis ("not acute") AND/OR dizziness AND/OR aphasia ("mild" OR "moderate")Discussion of neurologic symptoms in case conference, if indicated recommendation to GP: referral to neurologistDCM (→ GP)Case conference conducted, if indicated referral to specialist was recommended(3)Evaluation by DCM: Nursing care necessary?Baseline and first intervention visit conducted AND/OR CareNapD: unmet needs in hygiene AND/OR dental hygiene AND/OR dressing AND/OR household AND/OR health and mobilityEvaluation by DCM: Nursing care necessary? Recommendation to GP if indicatedDCM (→ GP)Evaluation conducted, if indicated nursing care was recommended to GP(4)Recommendation to GP: Indication check antidementive medicationICD diagnosis: dementia AND medication review: no antidementive medicationIndication check antidementive medicationDCM → GPIndication check conducted; antidementive drug prescribed(5)Recommendation to GP, delegation of intervention task to DCM possible: Arrange Patient DecreeSeverity of dementia: mild cognitive impairment OR mild dementia AND no Patient Decree AND Capability of the patient to grant consentArrange Patient DecreeDCM → GP (→ DCM)Recommendation to arrange Patient Decree given; Patient Decree arranged(6)Intervention task for DCM: Counsel caregiver regarding family and partnershipBIZA-D: Family and partnership: strain ≥3Counsel caregiver regarding family and partnershipDCMCounseling conducted(7)Emergency measure: Suicidal tendencyManifest suicidal intent/plan AND/OR suicidal actionNotification of emergency doctor or GP, stay with proband until help is ensuredDCMNotification of emergency doctor or GP, DCM has put their instructions into action[^5] (1)*In-depth assessment:* standard assessment indicated a specific problem; the DCM needs to do further in-depth assessment to plan further intervention(2)*Case conference:* assessment indicated a problem that needs to be discussed in an interdisciplinary case conference to decide whether a specific intervention task is indicated and should be recommended to the GP(3)*Evaluation of the situation by DCM*: some situations are too complex to address with predefined algorithms; the DCM has to assess the individual situation and decide whether specific intervention tasks are indicated(4)*Recommendation to GP:* assessment indicated a specific problem that needs to be addressed by GP and/or specialist(5)*Recommendation to GP, delegation of intervention task to DCM possible:* assessment indicated a specific problem; the DCM recommends a certain intervention task to the GP who can then delegate this task to the DCM(6)*Intervention task for DCM:* assessment indicated an intervention task that the DCM conducts on her own without involving the GP(7)*Emergency measure:* in case of emergency the DCM initiates and/or conducts predetermined emergency measures

Even though, in principle, the list of predefined intervention modules forms the basis of DelpHi-Intervention, the DCM is not restricted to it. On the one hand the DCM can take additional measures if necessary -- as long as these self-assigned tasks comply with principal requirements of the DelpHi-Intervention such as (1) not to double already established services but rather integrating the PwD into these or (2) not to violate patient autonomy. On the other hand it is not mandatory to conduct automatically generated intervention tasks if they do not seem appropriate from a clinical and/or nursing perspective. Non-conduction of such tasks needs to be reported and discussed in a case conference (see below). Reasons for adding as well as removing intervention tasks are documented.

Full documentation of both initiation and completion (including reasons for non-completion, if applicable) of all triggered as well as self-assigned intervention tasks is a vital part of the DelpHi-study.

A computer-assisted Intervention-Management-System (IMS) was developed to facilitate the planning and documentation of the DelpHi-Intervention. Rules for all predefined intervention modules were programmed. For data collection, the DCM uses a hand-held tablet computer with touch-screen functionality. All information entered by the DCM into the central DelpHi-information system is processed immediately (Meyer *et al*., [@ref026]). Whenever a predefined trigger condition is activated, the corresponding intervention task is automatically selected and assigned, including tasks for in-depth assessments and case conferences.

The DCM conducts all in-depth assessments indicated by the IMS (e.g. mobility tests, pain assessment, neuropsychiatric assessment) usually in her third home visit with the PwD. Based on these data, the IMS generates an individual preliminary list for the respective subject with suggestions for specific intervention tasks. This list is discussed and finalized in a weekly interdisciplinary case conference. Participants of this conference are the DCM, a nursing scientist, a neurologist/psychiatrist, a psychologist, and a pharmacist. The case conference is an important part of the study to check adherence to the study protocol as well as to assess the adequateness of the predefined intervention modules. Hence the case conference provides crucial information for later evaluation of the DelpHi-Intervention.

After the case conference the main results of the baseline and in-depth assessment as well as the finalized list of intervention tasks are summarized by the DCM in a semi-standardized GP- information letter that contains (1) a cover letter that gives a brief description of the patient\'s social, physical, and mental needs and resources as well as some prioritized suggestions for intervention, (2) a standardized report of the most important outcomes of baseline and in-depth assessments, and (3) a list of recommended intervention tasks. This letter is then discussed between GP and DCM to establish an individual treatment plan. Finally the GP decides whether s/he will conduct a suggested intervention task, delegate a task to the DCM, or rate a task as "not necessary."

The GP-information letter is the main instrument for communication and coordination of DCM and GP and ensures that the GP plays a key role in the context of the DelpHi-Intervention.

During the first six months of the intervention period, the DCM conducts home visits at least monthly, taking all necessary steps to carry out her designated intervention tasks in close cooperation with the caregiver, the GP, and various healthcare and social service professionals and facilities.

The subsequent six months the DCM monitors the completion of all intervention tasks, mainly by telephone, but also in additional home visits if necessary.

Follow-up assessment {#sec2-4}
--------------------

The intervention period is completed with the follow-up assessment after one year, which is conducted in the control group as well. To assess long-term effects of the intervention, annual follow-up assessments will be conducted in both groups for at least five years.

Expected results and discussion {#sec3}
===============================

We expect at least small effects of the DelpHi-Intervention, i.e. statistically significant differences between control and intervention groups across the primary outcomes. In concrete terms, we expect for the intervention group (1) better quality of life of the PwDs and their caregivers, (2) less behavioral and psychological symptoms of dementia, (3) more frequent medical treatment with antidementive drugs and less frequent potentially inadequate medication, and (4) less caregiver burden as in the control group. Comprehensive economic analyses will be conducted to determine the cost effectiveness of the DelpHi-Intervention, a prerequisite for the translation of DelpHi-Intervention into routine healthcare. For details and further information on intended statistical analyses, see the study protocol (Thyrian *et al*., [@ref036]).

The Delphi-Intervention meets two requirements for the effectiveness of collaborative care models (Somme *et al*., [@ref035]): (1) high intensity of care management, and (2) high level of integration. Pacala *et al*. ([@ref030]) defined a scale to rate case management intensity based on 18 different criteria. Only programs with high intensity of intervention and at least medium integration level reported moderate to medium clinical effects on their primary outcomes (Callahan *et al*., [@ref008]; Vickrey *et al*., [@ref038]), whereas low-intensity programs reported none or slight but clinically insignificant effects (Weinberger *et al*., [@ref041]; Yordi *et al*., [@ref044]; Bass *et al*., [@ref002]). The DelpHi-Intervention meets 14 of Pacala\'s criteria and can be classified as "high intensity" case management accordingly. Integration level can be rated "high" as well: the DCMs cooperate closely with caregivers, GPs, and various healthcare and social service professionals and facilities to integrate PwDs into the established healthcare and social service system.

With the Delphi-Intervention we want to provide "optimum care" to PwDs and their caregivers. The intervention is comprehensive, integrative, multi-professional, multimodal, individualized, and therefore highly complex. To facilitate the handling of this complexity, the computer-assisted IMS was developed. To our knowledge, DelpHi-MV is the first randomized controlled intervention trial to utilize a comprehensive computer-assisted management system for ambulant dementia care management. The deployment of IMS has several benefits. It helps to ensure that all individual needs and resources of the PwDs and their caregivers as well as all necessary intervention tasks according to the "DelpHi-Standard" are considered by the DCM. However, IMS is merely an instrument to support the work of the DCM. In collaboration with the interdisciplinary case conference, the DCM has to assess the adequateness of each intervention task generated by IMS as well as to decide if additional interventions are required. Hence the IMS does neither take any decision nor provides diagnosis or therapeutical advice; thus it complies to legal requirements of the German Medical Products Law (MPG; Bundesministerium der Justiz, [@ref006]).

Besides IMS supports adherence of the DCM to the study protocol, thereby enhancing the quality of implementation of the DelpHi-Intervention. IMS is also a valuable tool for the evaluation of the DelpHi-Intervention. It enables the analysis of research questions such as: (1) which intervention tasks were generated under which conditions, (2) what were the most frequently generated intervention tasks, (3) what are the reasons for non-conduction of intervention tasks, (4) which interventions had an impact on primary outcomes, (5) which intervention tasks were delegated by GP to the DCM, (6) which intervention tasks were successfully conducted, and (7) which intervention tasks were rated as not necessary by the GP. Results of these analyses will not only provide answers to these questions but will also be used for refinements of DelpHi-Intervention by adding missing intervention modules and adapting inappropriate trigger conditions and/or subsequent intervention tasks.

Results of this study can provide evidence for the effectiveness and efficacy of collaborative dementia care management according to the "Delphi-Standard," paving the way for translating this innovative concept into routine healthcare.
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[^1]: ^1^Primary outcome measure.
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